Cannvas Secures Revenue Agreement with Medical Marihuana Patient Relief

Published: May 1, 2019

Cannvas MedTech Inc., a digital cannabis education and analytics company, signed of a revenue sharing agreement with Medical Marihuana Patient Relief Inc., a private locally-owned producer based in Tecumseh, Ontario focused on creating high-quality, in-demand medical cannabis strains. Cannvas and MM Patient Relief are jointly deploying technologies to increase value-added services offered between company platforms while driving customer integration.

“We are proud to have developed the leading digital cannabis education resource for Canadians curious about the potential benefits of cannabis consumption, and this partnership with Medical Marihuana Patient Relief adds value to each of our communities,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech. “Providing MM Patient Relief’s community with better access to cannabis education while Cannvas.Me users gain an option to follow up with MM Patient Relief for their therapeutic cannabis needs, if they so choose, ensures a mutually beneficial scenario.”

Cannvas expects to leverage its data analysis capabilities and work with MM Patient Relief to generate revenue through tracking the number of Cannvas.Me users who choose MM Patient Relief as their primary cannabis provider, and can track purchases made throughout the lifetime of a patient. Established in 2014, Medical Marihuana Patient Relief Inc. is currently in the final stages of review and approval under Health Canada’s MMPR/ACMPR (Access to Cannabis for Medical Purposes Regulations).